$503 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 24 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 60.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
OPK | Buy | OPKO HEALTH INC | $18,751,000 | -24.8% | 3,826,760 | +5.2% | 3.73% | -8.9% |
BIOL | Buy | BIOLASE INC | $13,161,000 | +19.2% | 30,866,262 | +68.5% | 2.62% | +44.3% |
ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $6,899,000 | +20.0% | 1,032,721 | +47.1% | 1.37% | +45.4% |
ARNA | Buy | ARENA PHARMACEUTICALS INC | $4,778,000 | +191.0% | 140,666 | +118.5% | 0.95% | +252.8% |
SLNO | New | SOLENO THERAPEUTICS INC | $4,299,000 | – | 2,388,060 | +100.0% | 0.85% | – |
CFRX | Buy | CONTRAFECT CORP | $2,929,000 | +20.9% | 2,900,417 | +32.9% | 0.58% | +46.6% |
ELGX | New | ENDOLOGIX INC | $1,941,000 | – | 362,727 | +100.0% | 0.39% | – |
QDEL | New | QUIDEL CORPcall | $729,000 | – | 104,800 | +100.0% | 0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
BIOGEN INC | 42 | Q3 2023 | 0.6% |
QUIDEL CORP | 36 | Q1 2022 | 52.5% |
AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
VERMILLION INC | 28 | Q1 2020 | 3.8% |
AGENUS INC | 25 | Q3 2023 | 9.8% |
TESARO INC | 23 | Q4 2018 | 27.8% |
ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.